Tokyo, June 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061902) titled 'Clinical significance of the Mini Nutritional Assessment-Short Form (MNA-SF) in patients with lung cancer' on June 16.
Study Type:
Observational
Primary Sponsor:
Institute - Seirei Hamamatsu General Hospital
Condition:
Condition - lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To determine whether MNA-SF is a predictor of prognosis in lung cancer patients.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with stage IV non-small cell lung cancer (NSCLC) hospitalized between January 1, 2022, and December 31, 2023.
Key exclusion criteria - Patients under the age of 18
Target Size - 60
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 05 Month 30 Day
Date of IRB - 2025 Year 07 Month 18 Day
Anticipated trial start date - 2025 Year 06 Month 30 Day
Last follow-up date - 2025 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067465
Disclaimer: Curated by HT Syndication.
